Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2010
06/09/2010CN101724011A Preparation method and application of tumor tissue complete antigen
06/09/2010CN101724010A Preparation method and application of tumor tissue complete antigen
06/09/2010CN101721676A Gene regulatory peptides
06/09/2010CN101250498B Method for culturing liver cell by hepatocyte-carrying growth factor polylactic acid-0-carboxymethyl shellglycan nano partical
06/09/2010CN101190943B Jiangzhe snake venom double-chain peptide, preparation method and application thereof
06/09/2010CN101186646B Application of king cobra toxin protease inhibitor and its derivatives
06/09/2010CN101182352B Transcription activating factor as well as coding gene and application thereof
06/09/2010CN101139385B Vegetable stress-resistant related protein and its coding gene and application
06/09/2010CN101121746B Jasmonic acid induced protein related to resistance of plant disease invasion and its coding gene and application
06/09/2010CN101014709B Gamma-butyrobetaine hydroxylase originated from neurospora crassa
06/08/2010US7732685 Plants and seeds of corn variety CV827360
06/08/2010US7732678 Cotton fiber transcriptional factors
06/08/2010US7732669 Regulatory sequences for regulation of gene expression in plants and other organisms, and compositions, products and methods related thereto
06/08/2010US7732668 nucleic acid fragment coding flowering locus t (FT) for use as tool in generating plants wijth enhanced shoot and flower development
06/08/2010US7732667 Abiotic stress tolerance protein for use as tool in generating drought resistant crop plants
06/08/2010US7732666 O-methyltransferase gene from sorghum cloning, expression, transformation and characterization
06/08/2010US7732665 Genetic engineering to modify genes in order to result in an ineffective target of the post-trascriptional gene silencing induced by geminiviruses; mutated polynucleotide sequence of a tomato infecting geminivirus
06/08/2010US7732663 Using transgene expression of enzyme inhibitors and associated factors to control morphological characteristics such as size and shape of crop plants
06/08/2010US7732661 producing a plant cell or plant with altered lignin composition by down-regulating expression of an endogenous polypeptide that has ferulate 5-hydroxylase (F5H) activity
06/08/2010US7732628 Such as 4-[8-(2-cyanoethyl-N,N-diisopropylphosphoramidyloxy)-2-aza-1-oxooct-1-yl]benzaldehyde, 4-[8-(2-cyanoethyl-N,N-diisopropylphosphoramidyloxy)-2-aza-1-oxooct-1-yl]acetophenone; for incorporation into oligonucleotides during immobilization and conjugation of biopolymers in solid phase synthesis
06/08/2010US7732588 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue
06/08/2010US7732587 for treatment of TNF-mediated diseases, particularly including chronic inflammatory diseases
06/08/2010US7732580 include a recombinant polypeptide that contains from its N-terminus to C-terminus a C-terminal fragment of MAP protein Map3527, a Map1519 protein amino acid sequence, followed by an N-terminal portion of Map3527; Johne's disease
06/08/2010US7732576 for identification on human chromosome 10 of a tumor suppressor gene;
06/08/2010US7732572 Modified growth hormone protein for use in prevention and treatment of cachexia associated with secondary effect of viral or metabolic diseases
06/08/2010US7732571 relate to various cell proliferative disorders, especially those involving muscle, nerve, and adipose tissue
06/08/2010US7732570 Alteration of Fc-fusion protein serum half-lives by mutagenesis
06/08/2010US7732568 Methods for preventing and treating Alzheimer's disease
06/08/2010US7732566 a protein originating from latex that can induce an allergic reaction in persons sensitized to the protein
06/08/2010US7732565 Compositions and methods relating to elutable carbohydrate-binding proteins
06/08/2010US7732423 Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis
06/08/2010US7732422 TRPM-2 antisense therapy
06/08/2010US7732409 EspFU nucleic acids and proteins and uses thereof
06/08/2010US7732407 Method for treatment of demyelinating central nervous system disease
06/08/2010US7732400 Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
06/08/2010US7732188 Protozoan strains of reduced virulence and use thereof
06/08/2010US7732182 Antisense agents for use intreatment and prevention of nervous system, bone skin, cell proliferative, inflammatory, pain and viral disorders
06/08/2010US7732167 Interferon-α/β binding fusion proteins and therapeutic uses thereof
06/08/2010US7732165 recombinant polynucleotide that encodes a cell surface polypeptide comprising a biomolecule partition motif that can direct targeting of intracellular polypeptides to and through membranes, including cell surface membranes
06/08/2010US7732151 insulin receptor substrate (IRS) proteins; assay for determining the ability of an enzyme, functional fragment, or functional derivative thereof to modify the phosphorylation status of a biotinylated polypeptide
06/08/2010US7732148 Annexin A3 for prostate cancer diagnosis
06/08/2010US7732147 Using muscle specific tyrosine kinase as autoantibody screening tool and evaluative indicator of myasthenia gravis
06/08/2010US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor
06/08/2010US7732130 Immunoprotective influenza antigen and its use in vaccination
06/08/2010US7732129 use of low-medium perfusion rates in an attached cell culture system to provide for improved yields; improved Ad-p53 production with cells grown in serum-free conditions; offers scalability, validatability and virus purity comparable to that achieved using CsCl gradient ultracentrifugation
06/08/2010US7731980 Polymorphic membrane proteins (pmp), amino acid and nucleotide sequences, antibodies specific for polymorphic membrane proteins, polypeptides, prophylactic and therapeutic compositions
06/08/2010US7731978 nontoxic oxygen labile streptolysin protein induces an immune response against Streptococcus pyogenes
06/08/2010US7731975 Chimeric filovirus glycoprotein
06/08/2010US7731971 for use in second generation HIV vaccines and as diagnostic tools in the treatment and control of HIV infection; define a critical balance between MHC affinity and receptor crossreactivity required for effective epitope enhancement and also demonstrate construction and efficacy of
06/08/2010US7731970 Variants of the major allergen Phl p 1 from timothy grass
06/08/2010US7731961 Methods of increasing muscle mass or muscle strength using antibody inhibitors of GDF-8
06/08/2010US7731959 Antagonists of neuropilin receptor function and use thereof
06/08/2010US7731946 Methods and compositions for modulating T helper (TH) cell development and function
06/08/2010US7731653 System and method for genetically treating cardiac conduction disturbances
06/08/2010CA2422295C A gene of aluminum-activated malate transporter of a plant and a protein encoded by the gene
06/08/2010CA2380611C Molecular motor
06/08/2010CA2320390C Pna and dna conjugates and methods for preparation thereof
06/08/2010CA2289916C A novel strain of bacillus for controlling plant diseases and corn rootworm
06/08/2010CA2266342C Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
06/08/2010CA2158047C Allergenic protein and peptides from house dust mite and uses therefor
06/08/2010CA2144475C Polyamide-oligonucleotide derivatives, their preparation and use
06/08/2010CA1341606C Activation of nf-kb precursor
06/03/2010WO2010062995A2 Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2
06/03/2010WO2010062903A2 Genomic sequencing using modified protein pores and ionic liquids
06/03/2010WO2010062859A2 Recombinantly expressed plasmodium celtos antigen and methods of use thereof
06/03/2010WO2010062768A1 Method for the treatment of hemophilia
06/03/2010WO2010062756A2 Preventing and treating sepsis
06/03/2010WO2010062518A1 Sulfonylurea-responsive repressor proteins
06/03/2010WO2010062399A2 Csf1r extracellular domain fusion molecules and treatments using same
06/03/2010WO2010062396A2 Virus like particle compositions and methods of use
06/03/2010WO2010062395A2 Identification of porcine reproductive and respiratory syndrome virus
06/03/2010WO2010062383A2 Stabilized receptor polypeptides and uses thereof
06/03/2010WO2010062365A2 A method of protecting against heart failure
06/03/2010WO2010061984A1 Novel antibiotic peptide derived from ribosomal protein l 1 of helicobacter pylori and use thereof
06/03/2010WO2010061923A1 Amino acid sequence, dna, and enzyme producing method
06/03/2010WO2010061915A1 Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes
06/03/2010WO2010061902A1 Screening method, composition containing substance selected by the screening method, and binding substance
06/03/2010WO2010061575A1 Promoter for low temperature fermentation of yeast, and culture medium for growing yeast and method for producing fermented food or beverage each of which utilizes the promoter
06/03/2010WO2010061404A1 A method of expressing foreign protein in plastids
06/03/2010WO2010061393A1 He4 variant nucleotide and amino acid sequences, and methods of use thereof
06/03/2010WO2010061283A2 Biomarkers for diagnosing and detecting the progression of neurodegenerative disorders, in particular of amyotrophic lateral sclerosis
06/03/2010WO2010061226A1 Composition and method for enhanced secretion of peptides and proteins from bacteria
06/03/2010WO2010061204A1 Cecropin-magainin hybrid peptides
06/03/2010WO2010061203A1 Biocidal fusion peptide comprising ll-37
06/03/2010WO2010060934A2 Cnnm proteins and uses thereof
06/03/2010WO2010060901A1 Peptides for treatment of obesity
06/03/2010WO2010060811A2 Surface active proteins as excipients in solid pharmaceutical formulations
06/03/2010WO2010060748A1 Binding proteins inhibiting the vegf-a receptor interaction
06/03/2010WO2010060618A1 Monomeric variants of he tetrameric eqfp611
06/03/2010WO2010060609A1 Expression cassettes for seed-specific expression in plants
06/03/2010WO2010060439A1 Detecting antigen responsive cells in a sample
06/03/2010WO2010060270A1 Novel strongly salt-tolerant gene nhxfs1 of plant, encoding protein and uses thereof
06/03/2010WO2010060265A1 Neuregulin peptides and their use
06/03/2010WO2010060188A1 Hosts and fermentation processes for cellulase production
06/03/2010WO2010033854A3 Avian derived fusion proteins
06/03/2010WO2010033220A3 Modified therapeutics peptides, methods of their preparation and use
06/03/2010WO2010033204A3 Polymer conjugates of c-peptides
06/03/2010WO2010027729A3 Gonococcal vaccines
06/03/2010WO2010021822A3 Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites
06/03/2010WO2009158035A3 Methods for dosing an activin-actriia antagonist and monitoring of treated patients
1 ... 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 ... 2916